Akouos to Present at Piper Sandler 33rd Annual Virtual Healthcare Conference
22 November 2021 - 11:00PM
Akouos, Inc. (“Akouos”) (NASDAQ: AKUS), a precision genetic
medicine company dedicated to developing potential gene therapies
for individuals living with disabling hearing loss worldwide, today
announced that Manny Simons, Ph.D., M.B.A., co-founder, president,
and chief executive officer of Akouos, participated in a
pre-recorded fireside chat that will be published today as part of
the Piper Sandler 33rd Annual Healthcare Conference taking place
November 29 to December 2, 2021.
The fireside chat will be available for on-demand viewing
through the investor section of Akouos’s website at www.akouos.com
beginning today, Monday, November 22, 2021, and will be available
for 14 days following the conference.
About Akouos
Akouos is a precision genetic medicine company dedicated to
developing gene therapies with the potential to restore, improve,
and preserve high-acuity physiologic hearing for individuals living
with disabling hearing loss worldwide. Leveraging its precision
genetic medicine platform that incorporates a proprietary
adeno-associated viral (AAV) vector library and a novel delivery
approach, Akouos is focused on developing precision therapies for
forms of sensorineural hearing loss. Headquartered in Boston,
Akouos was founded in 2016 by leaders in the fields of neurotology,
genetics, inner ear drug delivery, and AAV gene therapy.
Contacts
Media:Katie Engleman, 1ABkatie@1abmedia.com
Investors:Courtney Turiano, Stern Investor
RelationsCourtney.Turiano@sternir.com
Akouos (NASDAQ:AKUS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Akouos (NASDAQ:AKUS)
Historical Stock Chart
From Apr 2023 to Apr 2024
Real-Time news about Akouos Inc (NASDAQ): 0 recent articles
More News Articles